Cellularly, LNCaP, a hormone-dependent prostate cancer cell, expresses wild-type p53; whereas, PC3 and DU145, hormone-independent prostate cancer cells, loses p53 expression and expresses mutant-type p53, respectively. This evidence concerns the gene TP53 and prostate carcinoma.